Your session is about to expire
← Back to Search
Early postpartum visit for Postpartum Depression
N/A
Waitlist Available
Led By Martha B Kole-White, MD
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial assesses if an extra early postpartum visit improves attendance at postpartum visits, education, satisfaction, or trust in clinicians.
Eligible Conditions
- Postpartum Weight Retention
- Postpartum Depression
- Patient Satisfaction
- Trust
- Breastfeeding
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of postpartum visits attended
Secondary outcome measures
Number of emergency room visits
Number of recommended items covered during postpartum care
Short Assessment of Patient Satisfaction
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Early & Often Postpartum CareExperimental Treatment2 Interventions
Visit at 2-3 and 6 weeks postpartum.
Group II: Standard Postpartum CarePlacebo Group1 Intervention
Visit at 6 weeks postpartum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Early postpartum visit
2021
N/A
~170
Standard postpartum visit
2021
N/A
~170
Find a Location
Who is running the clinical trial?
Women and Infants Hospital of Rhode IslandLead Sponsor
110 Previous Clinical Trials
38,651 Total Patients Enrolled
3 Trials studying Postpartum Depression
950 Patients Enrolled for Postpartum Depression
Martha B Kole-White, MDPrincipal InvestigatorWomen & Infants Hospital
Share this study with friends
Copy Link
Messenger